Which medication is classified as a Schedule 3N drug?

The medication classified as a Schedule 3N drug is Buprenorphine, which is commonly found in formulations like Suboxone. Schedule 3 medications are those that have a moderate potential for abuse and can lead to physical dependence or high psychological dependence. Buprenorphine is specifically recognized for its use in treating opioid addiction due to its partial agonist effects on the mu-opioid receptors, which help to alleviate withdrawal symptoms and cravings without producing the same level of euphoria as full agonists. This classification aims to manage its use effectively and minimize the risk of misuse while allowing it to be available for legitimate medical purposes.

In contrast, Phenobarbital is classified under Schedule 4, which includes drugs with a lower potential for abuse. Codeine, depending on the formulation and quantity, can be classified under different schedules; for example, lower doses combined with other medications may be Schedule 3, but not all formulations are. Lyrica (pregabalin) is classified as a Schedule 5 medication, indicating an even lower potential for abuse compared to Schedule 3 drugs. Understanding these classifications is crucial for healthcare professionals to ensure proper prescribing practices and compliance with regulatory standards.